Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$138K Buy
+548
New +$118K 0.03% 152
2025
Q1
Sell
-50
Closed -$8.88K 116
2024
Q4
$8.88K Buy
+50
New +$9.19K 0.01% 347

Other funds holding ABBV

Fedenia Advisers's ABBV Position: Q2 2026 in Review

Fedenia Advisers opened a new position in AbbVie (ABBV) in Q2 2026: 548 shares worth $138K. The stake represents 0.03% of the portfolio and ranks #152 among its holdings. This is a return to the name: Fedenia Advisers previously reported a position in ABBV as recently as Q4 2024.

Fedenia Advisers first reported a position in ABBV in Q4 2024 and has held it in 2 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fedenia Advisers held 548 shares of AbbVie worth $138K as of Q2 2026.
  • AbbVie was a new Fedenia Advisers position in Q2 2026.
  • AbbVie made up 0.03% of Fedenia Advisers's portfolio in Q2 2026, its #152 holding.
  • Fedenia Advisers first reported a position in AbbVie in Q4 2024 and has held it in 2 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fedenia Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.